Gene name: Cd1d1
Protein name: CD1d1 antigen
List of molecules and drugs that interact with protein A0A0R4J090
| # | DrugDomain Data | PBD ligand | DrugBank Accession | PubChem | ChEMBL | Name | Drug action | Affinity data |
|---|---|---|---|---|---|---|---|---|
| 1 | A0A0R4J090_7LM | 7LM | n/a | 129900335 | n/a | N-[(2S,3S,4R)-1-(alpha-D-galactopyranosyloxy)-3,4-dihydroxy-16-phenylhexadecan-2-yl]octanamide | n/a | |
| 2 | A0A0R4J090_7LP | 7LP | n/a | 129900334 | n/a | (5R,6S,7S)-5,6-dihydroxy-7-(octanoylamino)-N-(6-phenylhexyl)-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octanamide | n/a | |
| 3 | A0A0R4J090_AGH | AGH | DB12232 | 2826713 | CHEMBL384200 | N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]-2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE | n/a | |
| 4 | A0A0R4J090_EL7 | EL7 | n/a | 137349261 | n/a | N-[(2S,3S,4R)-3,4-dihydroxy-8-oxo-8-[(6-phenylhexyl)amino]-1-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octan-2-yl]heptadecanamide (non-preferred name) | n/a | |
| 5 | A0A0R4J090_ELG | ELG | n/a | 137321187 | n/a | (5R,6S,7S)-5,6-dihydroxy-7-(octanoylamino)-N-(3-pentylphenyl)-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)te trahydro-2H-pyran-2-yl]oxy}octanamide | n/a | |
| 6 | A0A0R4J090_ELM | ELM | n/a | 137321182 | n/a | N-[(2S,3S,4R)-3,4-dihydroxy-8-oxo-8-[(6-phenylhexyl)amino]-1-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetra hydro-2H-pyran-2-yl]oxy}octan-2-yl]dodecanamide | n/a | |
| 7 | A0A0R4J090_ELS | ELS | n/a | 137321186 | n/a | N-[(2S,3S,4R)-3,4-dihydroxy-8-oxo-8-[(4-pentylphenyl)amino]-1-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetr ahydro-2H-pyran-2-yl]oxy}octan-2-yl]hexacosanamide | n/a | |
| 8 | A0A0R4J090_EM4 | EM4 | n/a | 137321185 | n/a | N-[(2S,3S,4R)-3,4-dihydroxy-8-oxo-8-[(6-phenylhexyl)amino]-1-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octan-2-yl]hexacosanamide | n/a | |
| 9 | A0A0R4J090_EMG | EMG | n/a | 137321184 | n/a | N-[(2S,3S,4R)-3,4-dihydroxy-8-oxo-8-[(6-phenylhexyl)amino]-1-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octan-2-yl]icosanamide | n/a | |
| 10 | A0A0R4J090_FJJ | FJJ | n/a | n/a | n/a | (5R,6S,7S)-5,6-dihydroxy-7-(octanoylamino)-N-[(1E)-4-phenylbutylidene]-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octanamide (non-preferred name) | n/a | |
| 11 | A0A0R4J090_FJM | FJM | n/a | 131801219 | n/a | (5R,6S,7S)-5,6-dihydroxy-7-(octanoylamino)-N-(8-phenyloctyl)-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octanamide (non-preferred name) | n/a | |
| 12 | A0A0R4J090_FO4 | FO4 | n/a | n/a | n/a | sphingomyelin | n/a | |
| 13 | A0A0R4J090_GOL | GOL | DB09462 | 753 | CHEMBL692 | GLYCEROL | n/a | |
| 14 | A0A0R4J090_J76 | J76 | n/a | 137321188 | n/a | (5R,6S,7S)-5,6-dihydroxy-7-(octanoylamino)-N-(4-pentylphenyl)-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)te trahydro-2H-pyran-2-yl]oxy}octanamide | n/a | |
| 15 | A0A0R4J090_J81 | J81 | n/a | 137321180 | n/a | (5R,6S,7S)-5,6-dihydroxy-N-nonyl-7-(octanoylamino)-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octanamide (non-preferred name) | n/a | |
| 16 | A0A0R4J090_JTD | JTD | n/a | 135567476 | n/a | N-[(2S,3S,4R)-1-{[4-O-(cyclopropylmethyl)-alpha-D-galactopyranosyl]oxy}-3,4-dihydroxyoctadecan-2-yl]hexacosanamide | n/a | |
| 17 | A0A0R4J090_JTG | JTG | n/a | 137349618 | n/a | N-[(2S,3S,4R)-3,4-dihydroxy-1-{[4-O-(prop-2-en-1-yl)-alpha-D-galactopyranosyl]oxy}octadecan-2-yl]hexacosanamide | n/a | |
| 18 | A0A0R4J090_JTJ | JTJ | n/a | 135567475 | n/a | N-[(2S,3S,4R)-3,4-dihydroxy-1-({4-O-[(4-methylphenyl)methyl]-alpha-D-galactopyranosyl}oxy)octadecan-2-yl]hexacosanamide | n/a | |
| 19 | A0A0R4J090_JTM | JTM | n/a | 135567474 | CHEMBL4103817 | N-[(2S,3S,4R)-1-({4-O-[(4-chlorophenyl)methyl]-alpha-D-galactopyranosyl}oxy)-3,4-dihydroxyoctadecan-2-yl]hexacosanamide | n/a | |
| 20 | A0A0R4J090_JTV | JTV | n/a | 135567472 | n/a | N-{(2S,3S,4R)-1-[(4-O-benzyl-alpha-D-galactopyranosyl)oxy]-3,4-dihydroxyoctadecan-2-yl}hexacosanamide | n/a | |
| 21 | A0A0R4J090_JU1 | JU1 | n/a | 135567471 | n/a | N-[(2S,3S,4R)-1-({4-O-[(4-tert-butylphenyl)methyl]-alpha-D-galactopyranosyl}oxy)-3,4-dihydroxyoctadecan-2-yl]hexacosanamide | n/a | |
| 22 | A0A0R4J090_JU4 | JU4 | n/a | 135567477 | n/a | N-[(2S,3S,4R)-1-({4-O-[(3,4-dichlorophenyl)methyl]-alpha-D-galactopyranosyl}oxy)-3,4-dihydroxyoctadecan-2-yl]hexacosanamide | n/a | |
| 23 | A0A0R4J090_JUD | JUD | n/a | 135567478 | n/a | N-{(2S,3S,4R)-3,4-dihydroxy-1-[(4-O-{[4-(trifluoromethyl)phenyl]methyl}-alpha-D-galactopyranosyl)oxy]octadecan-2-yl}hexacosanamide | n/a | |
| 24 | A0A0R4J090_MVV | MVV | n/a | 146035905 | n/a | (2R)-1-(alpha-D-glucopyranosyloxy)-3-(octadecanoyloxy)propan-2-yl (9Z)-octadec-9-enoate | n/a | |
| 25 | A0A0R4J090_NA | NA | n/a | 923 | n/a | SODIUM ION | n/a | |
| 26 | A0A0R4J090_NAG | NAG | DB00141 | 24139 | CHEMBL447878 | 2-acetamido-2-deoxy-beta-D-glucopyranose | n/a | |
| 27 | A0A0R4J090_PLM | PLM | DB03796 | 985;135369651; | CHEMBL82293 | PALMITIC ACID | n/a | |
| 28 | A0A0R4J090_QWV | QWV | n/a | 132473005 | n/a | N-[(2S,3R)-3-hydroxy-1-{[6-O-(3-phenylpropanoyl)-alpha-D-galactopyranosyl]oxy}octadecan-2-yl]hexacosanamide | n/a | |
| 29 | A0A0R4J090_UNL | UNL | n/a | |||||
| 30 | A0A0R4J090_SO4 | SO4 | DB14546 | 1117 | n/a | SULFATE ION | n/a |